{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:07:55Z","timestamp":1792454875101,"version":"4.5.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.rdc.2020.05.005","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T17:59:02Z","timestamp":1591811942000},"page":"533-550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Cancer and Systemic Lupus Erythematosus"],"prefix":"10.1016","volume":"46","author":[{"given":"Alexandra","family":"Ladouceur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basile","family":"Tessier-Cloutier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann E.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalind","family":"Ramsey-Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasha","family":"Bernatsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2020.05.005_bib1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jaut.2012.12.009","article-title":"Cancer risk in systemic lupus: an updated international multi-centre cohort study","volume":"42","author":"Bernatsky","year":"2013","journal-title":"J\u00a0Autoimmun"},{"issue":"8","key":"10.1016\/j.rdc.2020.05.005_bib2","first-page":"887","article-title":"Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California","volume":"19","author":"Parikh-Patel","year":"2008","journal-title":"Cancer Causes Control"},{"issue":"3","key":"10.1016\/j.rdc.2020.05.005_bib3","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1177\/0961203313520060","article-title":"Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis","volume":"23","author":"Ni","year":"2014","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.rdc.2020.05.005_bib4","doi-asserted-by":"crossref","first-page":"e0122964","DOI":"10.1371\/journal.pone.0122964","article-title":"Systemic lupus erythematous and malignancy risk: a meta-analysis","volume":"10","author":"Cao","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.rdc.2020.05.005_bib5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s13075-018-1760-3","article-title":"The risks of cancer development in systemic lupus erythematosus (SLE) patients: a systematic review and meta-analysis","volume":"20","author":"Song","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2020.05.005_bib6","first-page":"1","article-title":"Increased incidence of cancer in systemic lupus erythematosus: a Finnish cohort study with more than 25 years of follow-up","author":"Tallbacka","year":"2018","journal-title":"Scand J Rheumatol"},{"issue":"9","key":"10.1016\/j.rdc.2020.05.005_bib7","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.3899\/jrheum.101190","article-title":"Expression of APRIL in diffuse large B cell lymphomas from patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"38","author":"Lofstrom","year":"2011","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2020.05.005_bib8","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-89-6-888","article-title":"Increased risk of lymphoma in sicca syndrome","volume":"89","author":"Kassan","year":"1978","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.rdc.2020.05.005_bib9","first-page":"2551","article-title":"Prevalence of factors influencing cancer risk in women with lupus: social habits, reproductive issues, and obesity","volume":"29","author":"Bernatsky","year":"2002","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2020.05.005_bib10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/03009740252937568","article-title":"Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus","volume":"31","author":"Bjornadal","year":"2002","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2020.05.005_bib11","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/art.1780400424","article-title":"Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus","volume":"40","author":"Mellemkjaer","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.rdc.2020.05.005_bib12","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1177\/0961203313497118","article-title":"Cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study","volume":"22","author":"Dey","year":"2013","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/j.rdc.2020.05.005_bib13","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/bjc.2011.115","article-title":"Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis","volume":"104","author":"Bernatsky","year":"2011","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.rdc.2020.05.005_bib14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000353138","article-title":"Breast cancer in systemic lupus erythematosus","volume":"85","author":"Tessier Cloutier","year":"2013","journal-title":"Oncology"},{"issue":"5","key":"10.1016\/j.rdc.2020.05.005_bib15","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/sj.bjc.6604906","article-title":"Breast cancer risk in elderly women with systemic autoimmune rheumatic diseases: a population-based case-control study","volume":"100","author":"Gadalla","year":"2009","journal-title":"Br J Cancer"},{"issue":"8093","key":"10.1016\/j.rdc.2020.05.005_bib16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0140-6736(78)92645-4","article-title":"Systemic lupus erythematosus and lymphoma","volume":"2","author":"Green","year":"1978","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.rdc.2020.05.005_bib17","doi-asserted-by":"crossref","first-page":"1150.e1-6","DOI":"10.1016\/j.amjmed.2010.08.006","article-title":"Malignancy in systemic lupus erythematosus: a nationwide cohort study in Taiwan","volume":"123","author":"Chen","year":"2010","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.rdc.2020.05.005_bib18","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/art.21955","article-title":"Mortality in systemic lupus erythematosus","volume":"54","author":"Bernatsky","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2020.05.005_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.leukres.2018.11.004","article-title":"Systemic lupus erythematosus and lymphoma: Incidence, pathogenesis and biology","volume":"75","author":"Klein","year":"2018","journal-title":"Leuk Res"},{"issue":"1","key":"10.1016\/j.rdc.2020.05.005_bib20","doi-asserted-by":"crossref","first-page":"e000051","DOI":"10.1136\/lupus-2014-000051","article-title":"Patients with systemic lupus erythematosus and haematological malignancy at a tertiary care centre: timing, histopathology and therapy","volume":"1","author":"Knight","year":"2014","journal-title":"Lupus Sci Med"},{"issue":"1","key":"10.1016\/j.rdc.2020.05.005_bib21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/annrheumdis-2012-202099","article-title":"Lymphoma risk in systemic lupus: effects of disease activity versus treatment","volume":"73","author":"Bernatsky","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2020.05.005_bib22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000350165","article-title":"Non-lymphoma hematological malignancies in systemic lupus erythematosus","volume":"85","author":"Lu","year":"2013","journal-title":"Oncology"},{"issue":"10","key":"10.1016\/j.rdc.2020.05.005_bib23","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1136\/ard.2004.034504","article-title":"Non-Hodgkin's lymphoma in systemic lupus erythematosus","volume":"64","author":"Bernatsky","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.rdc.2020.05.005_bib24","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/0961203307079045","article-title":"Monoclonal gammopathy in systemic lupus erythematosus","volume":"16","author":"Ali","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2020.05.005_bib25","unstructured":"Ladouceur A, Clarke AE, Ramsey-Goldman R, et\u00a0al. Hematologic and non-hematologic cancer risk in a large inception SLE cohort. Canadian Rheumatology Association (CRA). Victoria, British Columbia, Canada, February 26\u201329, 2020."},{"issue":"3","key":"10.1016\/j.rdc.2020.05.005_bib26","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.21675","article-title":"Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis","volume":"54","author":"Baecklund","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.rdc.2020.05.005_bib27","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/ard.2004.022491","article-title":"Raised serum APRIL levels in patients with systemic lupus erythematosus","volume":"64","author":"Koyama","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.rdc.2020.05.005_bib28","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.4049\/jimmunol.172.5.3268","article-title":"Lymphoma B cells evade apoptosis through the TNF family members BAFF\/BLyS and APRIL","volume":"172","author":"He","year":"2004","journal-title":"J\u00a0Immunol"},{"issue":"25","key":"10.1016\/j.rdc.2020.05.005_bib29","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"20","key":"10.1016\/j.rdc.2020.05.005_bib30","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1182\/blood-2016-11-747022","article-title":"Genetic profiling of MYC and BCL2 in diffuse large B-cell lymphoma determines cell-of-origin-specific clinical impact","volume":"129","author":"Ennishi","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.rdc.2020.05.005_bib31","doi-asserted-by":"crossref","first-page":"e000324","DOI":"10.1136\/lupus-2019-000324","article-title":"Cell of origin in diffuse large B-cell lymphoma in systemic lupus erythematosus: molecular and clinical factors associated with survival","volume":"6","author":"Tessier-Cloutier","year":"2019","journal-title":"Lupus Sci Med"},{"issue":"7247","key":"10.1016\/j.rdc.2020.05.005_bib32","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nature07968","article-title":"Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma","volume":"459","author":"Compagno","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.rdc.2020.05.005_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kez011","article-title":"Bidirectional relationship between systemic lupus erythematosus and non-Hodgkin's lymphoma: a nationwide population-based study","author":"Wang","year":"2019","journal-title":"Rheumatology (Oxford)"},{"issue":"25","key":"10.1016\/j.rdc.2020.05.005_bib34","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1182\/blood-2013-05-503383","article-title":"Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren's syndrome","volume":"122","author":"Nocturne","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.rdc.2020.05.005_bib35","doi-asserted-by":"crossref","first-page":"e000187","DOI":"10.1136\/lupus-2016-000187","article-title":"Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma","volume":"4","author":"Bernatsky","year":"2017","journal-title":"Lupus Sci Med"},{"issue":"7","key":"10.1016\/j.rdc.2020.05.005_bib36","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/gepi.22242","article-title":"Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes","volume":"43","author":"Din","year":"2019","journal-title":"Genet Epidemiol"},{"issue":"3","key":"10.1016\/j.rdc.2020.05.005_bib37","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3892\/etm.2012.625","article-title":"Association of FAS gene polymorphisms with systemic lupus erythematosus: A case-control study and meta-analysis","volume":"4","author":"Lu","year":"2012","journal-title":"Exp Ther Med"},{"issue":"3","key":"10.1016\/j.rdc.2020.05.005_bib38","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1084\/jem.20010955","article-title":"Genetic dissection of SLE: SLE1 and FAS impact alternate pathways leading to lymphoproliferative autoimmunity","volume":"196","author":"Shi","year":"2002","journal-title":"J\u00a0Exp Med"},{"issue":"4","key":"10.1016\/j.rdc.2020.05.005_bib39","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/ard.51.4.437","article-title":"Increased risk of cancer in patients with systemic lupus erythematosus","volume":"51","author":"Pettersson","year":"1992","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.rdc.2020.05.005_bib40","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/ard.61.5.409","article-title":"Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades","volume":"61","author":"Moss","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.rdc.2020.05.005_bib41","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1191\/096120301678646128","article-title":"Systemic lupus erythematosus and the risk of malignancy","volume":"10","author":"Cibere","year":"2001","journal-title":"Lupus"},{"issue":"12","key":"10.1016\/j.rdc.2020.05.005_bib42","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1136\/ard.2006.067108","article-title":"A\u00a0closer look at non-Hodgkin's lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study","volume":"66","author":"Lofstrom","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2020.05.005_bib43","doi-asserted-by":"crossref","first-page":"482","DOI":"10.5114\/ceji.2018.81351","article-title":"Regulation of TLR signaling pathways by microRNAs: implications in inflammatory diseases","volume":"43","author":"Arenas-Padilla","year":"2018","journal-title":"Cent Eur J Immunol"},{"issue":"4","key":"10.1016\/j.rdc.2020.05.005_bib44","doi-asserted-by":"crossref","first-page":"pky082","DOI":"10.1093\/jncics\/pky082","article-title":"Markers of Immune Activation and Inflammation, and Non-Hodgkin Lymphoma: A Meta-Analysis of Prospective Studies","volume":"2","author":"Makgoeng","year":"2018","journal-title":"JNCI Cancer Spectr"},{"key":"10.1016\/j.rdc.2020.05.005_bib45","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.intimp.2018.09.024","article-title":"MYD88 L265P mutation promoted malignant B cell resistance against T\u00a0cell-mediated cytotoxicity via upregulating the IL-10\/STAT3 cascade","volume":"64","author":"Qiu","year":"2018","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"10.1016\/j.rdc.2020.05.005_bib46","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.tranon.2018.12.008","article-title":"STAT-3 RNAscope Determination in Human Diffuse Large B-Cell Lymphoma","volume":"12","author":"Tamma","year":"2019","journal-title":"Transl Oncol"},{"issue":"5","key":"10.1016\/j.rdc.2020.05.005_bib47","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/1529-0131(200105)44:5<1122::AID-ANR193>3.0.CO;2-D","article-title":"Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure","volume":"44","author":"James","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.rdc.2020.05.005_bib48","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1172\/JCI119856","article-title":"An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus","volume":"100","author":"James","year":"1997","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.rdc.2020.05.005_bib49","doi-asserted-by":"crossref","first-page":"R295","DOI":"10.1186\/ar1181","article-title":"Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood","volume":"6","author":"Moon","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2020.05.005_bib50","doi-asserted-by":"crossref","first-page":"535738","DOI":"10.1155\/2013\/535738","article-title":"Epstein-Barr virus in systemic autoimmune diseases","volume":"2013","author":"Draborg","year":"2013","journal-title":"Clin Dev Immunol"},{"issue":"11","key":"10.1016\/j.rdc.2020.05.005_bib51","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1517\/14712598.6.11.1193","article-title":"The role of Epstein-Barr virus in cancer","volume":"6","author":"Pattle","year":"2006","journal-title":"Expert Opin Biol Ther"},{"issue":"10","key":"10.1016\/j.rdc.2020.05.005_bib52","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1158\/1078-0432.CCR-10-2578","article-title":"Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes","volume":"17","author":"Saha","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.rdc.2020.05.005_bib53","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/ard.2006.069039","article-title":"The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study","volume":"67","author":"Bernatsky","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.rdc.2020.05.005_bib54","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1183\/09031936.00222911","article-title":"Effect of autoimmune diseases on risk and survival in histology-specific lung cancer","volume":"40","author":"Hemminki","year":"2012","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.rdc.2020.05.005_bib55","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.berh.2019.03.011","article-title":"Malignancy and rheumatoid arthritis: Epidemiology, risk factors and management","volume":"32","author":"De Cock","year":"2018","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.rdc.2020.05.005_bib56","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.3389\/fimmu.2018.03112","article-title":"Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors","volume":"9","author":"Maria","year":"2018","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.rdc.2020.05.005_bib57","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3899\/jrheum.170652","article-title":"Smoking Is the Most Significant Modifiable Lung Cancer Risk Factor in Systemic Lupus Erythematosus","volume":"45","author":"Bernatsky","year":"2018","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2020.05.005_bib58","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.lungcan.2007.01.007","article-title":"Lung cancer in systemic lupus erythematosus","volume":"56","author":"Bin","year":"2007","journal-title":"Lung Cancer"},{"issue":"8","key":"10.1016\/j.rdc.2020.05.005_bib59","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s10067-013-2224-4","article-title":"Smoking and the risk of systemic lupus erythematosus","volume":"32","author":"Ekblom-Kullberg","year":"2013","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2020.05.005_bib60","first-page":"1119","article-title":"Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer","volume":"32","author":"Franks","year":"2012","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.rdc.2020.05.005_bib61","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1164\/ajrccm.161.1.9906062","article-title":"Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study","volume":"161","author":"Hubbard","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.rdc.2020.05.005_bib62","doi-asserted-by":"crossref","first-page":"e0173339","DOI":"10.1371\/journal.pone.0173339","article-title":"Gene-set meta-analysis of lung cancer identifies pathway related to systemic lupus erythematosus","volume":"12","author":"Rosenberger","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.rdc.2020.05.005_bib63","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s10067-010-1606-0","article-title":"Systemic lupus erythematosus, human papillomavirus infection, cervical pre-malignant and malignant lesions: a systematic review","volume":"30","author":"Santana","year":"2011","journal-title":"Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2020.05.005_bib64","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.autrev.2014.03.001","article-title":"Increased risk of high grade cervical squamous intraepithelial lesions in systemic lupus erythematosus: A meta-analysis of the literature","volume":"13","author":"Zard","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.rdc.2020.05.005_bib65","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/annrheumdis-2013-204993","article-title":"Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study","volume":"74","author":"Kim","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2020.05.005_bib66","first-page":"613","article-title":"Cervical neoplasia in systemic lupus erythematosus: a nationwide study","volume":"56","author":"Wadstrom","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.rdc.2020.05.005_bib67","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.autrev.2014.08.004","article-title":"Increased risk of high-grade squamous intraepithelial lesions in systemic lupus erythematosus: additional data from Denmark","volume":"13","author":"Dugue","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.rdc.2020.05.005_bib68","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1002\/art.30483","article-title":"High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort","volume":"63","author":"Dreyer","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.rdc.2020.05.005_bib69","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/art.22667","article-title":"High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients","volume":"57","author":"Nath","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.rdc.2020.05.005_bib70","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.3346\/jkms.2010.25.10.1431","article-title":"Prevalence of human papilloma virus infections and cervical cytological abnormalities among Korean women with systemic lupus erythematosus","volume":"25","author":"Lee","year":"2010","journal-title":"J\u00a0Korean Med Sci"},{"issue":"2","key":"10.1016\/j.rdc.2020.05.005_bib71","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/acr.20367","article-title":"Risk factors for squamous intraepithelial lesions in systemic lupus erythematosus: a prospective cohort study","volume":"63","author":"Tam","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"10.1016\/j.rdc.2020.05.005_bib72","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/rheumatology\/keh331","article-title":"Factors associated with abnormal Pap results in systemic lupus erythematosus","volume":"43","author":"Bernatsky","year":"2004","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.rdc.2020.05.005_bib73","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/RHU.0b013e3181df5261","article-title":"Is higher prevalence of cervical intraepithelial neoplasia in women with lupus due to immunosuppression?","volume":"16","author":"Klumb","year":"2010","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.rdc.2020.05.005_bib74","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1002\/art.20616","article-title":"Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection","volume":"50","author":"Tam","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2020.05.005_bib75","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12969-016-0072-x","article-title":"HPV infection and vaccination in Systemic Lupus Erythematosus patients: what we really should know","volume":"14","author":"Grein","year":"2016","journal-title":"Pediatr Rheumatol Online J"},{"issue":"5","key":"10.1016\/j.rdc.2020.05.005_bib76","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/annrheumdis-2012-201393","article-title":"Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control study","volume":"72","author":"Mok","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"23","key":"10.1016\/j.rdc.2020.05.005_bib77","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1016\/j.vaccine.2018.04.056","article-title":"Long-term immunogenicity of a quadrivalent human papillomavirus vaccine in systemic lupus erythematosus","volume":"36","author":"Mok","year":"2018","journal-title":"Vaccine"},{"issue":"Rr-05","key":"10.1016\/j.rdc.2020.05.005_bib78","first-page":"1","article-title":"Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"63","author":"Markowitz","year":"2014","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"10.1016\/j.rdc.2020.05.005_bib79","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/annrheumdis-2019-215882","article-title":"2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"79","author":"Furer","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.rdc.2020.05.005_bib80","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.3899\/jrheum.171459","article-title":"Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus","volume":"45","author":"Keeling","year":"2018","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2020.05.005_bib81","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3899\/jrheum.090644","article-title":"Natural history of cervical papilloma virus infection in systemic lupus erythematosus - a prospective cohort study","volume":"37","author":"Tam","year":"2010","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2020.05.005_bib82","first-page":"45","article-title":"Cancer screening in patients with systemic lupus erythematosus","volume":"33","author":"Bernatsky","year":"2006","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2020.05.005_bib83","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","article-title":"EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome","volume":"76","author":"Andreoli","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.rdc.2020.05.005_bib84","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3109\/00016489.2013.800228","article-title":"Impact of head and neck malignancies on risk factors and survival in systemic lupus erythematosus","volume":"133","author":"Chang","year":"2013","journal-title":"Acta Otolaryngol"},{"issue":"8","key":"10.1016\/j.rdc.2020.05.005_bib85","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/ijc.28194","article-title":"Markers of HPV infection and survival in patients with head and neck tumors","volume":"133","author":"Koslabova","year":"2013","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.rdc.2020.05.005_bib86","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/archotol.129.10.1115","article-title":"Epstein-Barr virus detected in a head and neck squamous cell carcinoma cell line derived from an immunocompromised patient","volume":"129","author":"Sisk","year":"2003","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"8","key":"10.1016\/j.rdc.2020.05.005_bib87","first-page":"1705","article-title":"Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases","volume":"26","author":"Asten","year":"1999","journal-title":"J\u00a0Rheumatol"},{"issue":"10","key":"10.1016\/j.rdc.2020.05.005_bib88","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1136\/ard.2003.019125","article-title":"Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide","volume":"63","author":"Knight","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.rdc.2020.05.005_bib89","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1210\/jc.2009-0677","article-title":"Thyroid cancer in systemic lupus erythematosus: a case-control study","volume":"95","author":"Antonelli","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.rdc.2020.05.005_bib90","first-page":"480","article-title":"Increased risk of papillary thyroid cancer in systemic sclerosis associated with autoimmune thyroiditis","volume":"55","author":"Antonelli","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"13","key":"10.1016\/j.rdc.2020.05.005_bib91","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jama.2017.2719","article-title":"Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013","volume":"317","author":"Lim","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.rdc.2020.05.005_bib92","first-page":"411","article-title":"IARC monographs on the evaluation of carcinogenic risks to humans","volume":"Vol 26","year":"1981"},{"issue":"1","key":"10.1016\/j.rdc.2020.05.005_bib93","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/art.25061","article-title":"Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review","volume":"62","author":"Monach","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.rdc.2020.05.005_bib94","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10067-009-1332-7","article-title":"Incidence of cancer among female patients with systemic lupus erythematosus in Korea","volume":"29","author":"Kang","year":"2010","journal-title":"Clin Rheumatol"},{"issue":"8","key":"10.1016\/j.rdc.2020.05.005_bib95","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1177\/0961203315575587","article-title":"What investigations are needed to optimally monitor for malignancies in SLE?","volume":"24","author":"Tessier-Cloutier","year":"2015","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.rdc.2020.05.005_bib96","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.det.2018.07.009","article-title":"Skin cancer and immunosuppression","volume":"37","author":"Collins","year":"2019","journal-title":"Dermatol Clin"},{"issue":"4","key":"10.1016\/j.rdc.2020.05.005_bib97","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/DSS.0000000000001455","article-title":"Nonmelanoma Skin Cancer Risk in Patients With Inflammatory Bowel Disease Undergoing Thiopurine Therapy: A Systematic Review of the Literature","volume":"44","author":"Hagen","year":"2018","journal-title":"Dermatol Surg"},{"issue":"9","key":"10.1016\/j.rdc.2020.05.005_bib98","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/apt.12491","article-title":"Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease","volume":"38","author":"Moran","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rdc.2020.05.005_bib99","unstructured":"Bernatsky S, Ramsey-Goldman R, Urowitz M, et\u00a0al. Cancer risk in a large inception SLE cohort: effects of age, smoking and medications. ACR\/ARP Annual meeting. Atlanta, GA, November 8\u201313, 2019."},{"key":"10.1016\/j.rdc.2020.05.005_bib100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40738-015-0004-3","article-title":"Fertility and pregnancy in rheumatoid arthritis and systemic lupus erythematosus","volume":"1","author":"Bermas","year":"2015","journal-title":"Fertil Res Pract"},{"issue":"24","key":"10.1016\/j.rdc.2020.05.005_bib101","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa051135","article-title":"Combined oral contraceptives in women with systemic lupus erythematosus","volume":"353","author":"Petri","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.rdc.2020.05.005_bib102","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/art.10365","article-title":"Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study","volume":"46","author":"Cooper","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2020.05.005_bib103","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/0961203317713146","article-title":"Breast cancer in systemic lupus erythematosus (SLE): receptor status and treatment","volume":"27","author":"Chan","year":"2018","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.rdc.2020.05.005_bib104","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/ard.2006.067777","article-title":"Antimalarials may influence the risk of malignancy in systemic lupus erythematosus","volume":"66","author":"Ruiz-Irastorza","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.rdc.2020.05.005_bib105","first-page":"3837","article-title":"Autophagy-induced tumor dormancy in ovarian cancer","volume":"118","author":"Amaravadi","year":"2008","journal-title":"J\u00a0Clin Invest"},{"issue":"8","key":"10.1016\/j.rdc.2020.05.005_bib106","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/CAD.0b013e32832f4e50","article-title":"Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells","volume":"20","author":"Rahim","year":"2009","journal-title":"Anticancer Drugs"},{"issue":"1","key":"10.1016\/j.rdc.2020.05.005_bib107","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/sj.bjc.6600370","article-title":"Aspirin and lung cancer in women","volume":"87","author":"Akhmedkhanov","year":"2002","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.rdc.2020.05.005_bib108","first-page":"193","article-title":"Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks","volume":"21","author":"Moran","year":"2002","journal-title":"J\u00a0Environ Pathol Toxicol Oncol"},{"issue":"8","key":"10.1016\/j.rdc.2020.05.005_bib109","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1177\/0961203312443992","article-title":"Decreased breast cancer risk in systemic lupus erythematosus: the search for a genetic basis continues","volume":"21","author":"Bernatsky","year":"2012","journal-title":"Lupus"},{"issue":"157","key":"10.1016\/j.rdc.2020.05.005_bib110","doi-asserted-by":"crossref","first-page":"157ra142","DOI":"10.1126\/scitranslmed.3004385","article-title":"Targeting cancer with a lupus autoantibody","volume":"4","author":"Hansen","year":"2012","journal-title":"Sci Transl Med"},{"issue":"9064","key":"10.1016\/j.rdc.2020.05.005_bib111","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(96)10109-4","article-title":"Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium","volume":"349","year":"1997","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.rdc.2020.05.005_bib112","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.bbrc.2018.01.139","article-title":"Re-engineering and evaluation of anti-DNA autoantibody 3E10 for therapeutic applications","volume":"496","author":"Rattray","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"10.1016\/j.rdc.2020.05.005_bib113","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nrrheum.2016.23","article-title":"DNA-damaging autoantibodies and cancer: the lupus butterfly theory","volume":"12","author":"Noble","year":"2016","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2020.05.005_bib114","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/0961203316664595","article-title":"Breast cancer in systemic lupus","volume":"26","author":"Bernatsky","year":"2017","journal-title":"Lupus"},{"issue":"34","key":"10.1016\/j.rdc.2020.05.005_bib115","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1200\/JCO.2006.05.9584","article-title":"Quantification of regulatory T\u00a0cells enables the identification of high-risk breast cancer patients and those at risk of late relapse","volume":"24","author":"Bates","year":"2006","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X20300570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X20300570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:19:08Z","timestamp":1760181548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X20300570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":115,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0889857X20300570"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2020.05.005","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer and Systemic Lupus Erythematosus","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2020.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}